Keywords: bmp, sunstone, acquires, shengda, china, signed, agreement
BMP Sunstone acquires 50% of Shengda
Article | 26 January 2009
China's BMP Sunstone has signed an agreement to acquire 50% of Zhangjiakou Shengda Pharmaceutical for 20.0 million renminbi ($2.9 million) in cash, subject ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
